12/08/2026
Two cancer patients, both with unpaid pathology claims — one administered by Discovery Health (Pty) Ltd and the other by Momentum Health (Pty) Ltd. Yet their experiences were decidedly different!
Cancer treatment places immense emotional, physical and financial strain on patients and their families. In our opinion, one would expect medical schemes and their administrators to handle these cases supportively, minimise red tape, and avoid creating any further burdens for their members.
The cancer treatments in both these cases were approved and provided by Designated Service Providers (DSPs) of the respective schemes.
Since the treating doctors were DSPs, one would reasonably expect that the treatment provided would fall within the parameters and protocols of the Medical Schemes. AND, if the required treatments were wide of these, the DSP would obtain the necessary approval from the schemes
In both cases, the treating doctors ordered pathology tests that their respective medical schemes did not pay for, despite the doctors being scheme DSPs.
PATIENTS generally have NO control over the Pathology tests requested by the treating doctors. When we are seriously ill, exhausted by tests and treatments, we have to place our trust in our doctors.
a. The Wooltru Healthcare Fund administered by Momentum Health (Pty) Ltd experience.
The frail, elderly patient, or rather her emotionally exhausted family, was VIGOROUSLY pursued by Pathcare for R3 712,00 in unpaid pathology claims that were requested during her cancer treatment.
Claims Hound contacted Pathcare, requesting copies of the invoices relating to the short payments.
Pathcare agreed to suspend their debt collection process, affording Claims Hound some time to engage with the medical scheme without harassing the patient.
Claims Hound contacted the Principal Officer of Wooltru Health Care Fund and requested that the reasons for the short payments be investigated and that the outstanding amounts be paid as Prescribed Minimum Benefits (PMBs), in full, since the services were provided by a DSP.
Momentum Health (Pty) Ltd, the administrator of the scheme, advised that they were investigating the matter and immediately engaged with the service providers concerned.
They had all the necessary information at hand since they had processed the invoices for the service providers involved.
Three days later Momentum Health (Pty) Ltd advised that their review was completed and that the outstanding amounts would be paid to Pathcare, in full at their next claims payment run.
b. The Discovery Health Medical Scheme administered by Discovery Health (Pty) Ltd experience.
Lancet aggressively pursued the patient’s wife — and later widow — for an unpaid balance of R2 123,30 for pathology services requested by the treating oncologist.
The oncologist was a Discovery Designated Service Provider (DSP) and a member of the ICON oncology group used by Discovery as consultants for cancer treatments.
The extremely unwell patient was registered on the Discovery Oncology / Advanced Illness Benefit (AIB) program for cancer treatment.
Claims Hound asked Lancet for copies of the short-paid invoices and to suspend debt collection while it engaged with Discovery Health Medical Scheme.
Lancet provided the copies of the invoices and agreed to suspend their debt collection process.
Unfortunately, the debt collection process was NOT suspended and the harassment of the patient’s physically and mentally exhausted wife continued unabated.
At this time, his wife was his sole carer.
According to the Discovery Health Member Claim Statements the reason for the short payment was:
“You reached the Above Threshold Benefit limit. We will not pay further out of hospital claims.” (reason code 198)
Claims Hound emailed the Discovery Advanced Illness Benefit team, attaching the relevant Lancet invoices and Discovery Claims Transaction History.
We asked them to review the short payments because the treatment was for a Prescribed Minimum Benefit (PMB) condition and both the requesting and testing providers were Discovery DSPs.
Discovery responded almost immediately:
“Kindly note that the claims short-paid from the Oncology Benefit due to no authorisation for the pathology codes. The member’s healthcare provider may request for authorisation by submitting the treatment plan to [email protected]. This will be subject to Case Management review”
The reason provided was VERY DIFFERENT from the reason reflected on the Discovery Health Member Claim Statement!
Up to this point the member was NOT made aware that the treatment could qualify for payment if the treating doctor requested authorisation and provided an appropriate motivation!
We believe this is a SERIOUS programming error by Discovery Health (Pty) Ltd:
The reason code on the Member Claim Statement does not reflect the true reason for the short payment and, MORE IMPORTANTLY, the member is not told that the treatment may qualify for payment if supported by an appropriate motivation.
How many unsuspecting members are being robbed of their benefits in this manner!
Claims Hound escalated the matter to Discovery Health (Pty) Ltd’s executive office and copied the Principal Officer of the INDEPENDENT Discovery Health Medical Scheme in the correspondence.
In short, Discovery Health Medical Scheme was asked to contact its DSP and clarify why the non-qualifying pathology tests had been requested.
If the tests were found to be appropriate, Discovery was asked to pay Lancet.
If Discovery found the tests inappropriate, we asked them to insist that the treating doctor — its DSP — pay Lancet for ordering them.
It should be remembered that the DSP requested these tests, not the patient!
It would be reasonable for the patient to expect that services provided by a DSP for a PMB would be covered in FULL by the medical scheme.
It was further pointed out that Discovery expected the treating doctor to provide a motivation so that another doctor, the pathologist, could be paid.
Claims Hound asked whether Discovery would pay for this motivation?
For some reason they failed to respond to that question!
It is our understanding, from the Council for Medical Schemes Code of Conduct, that the scheme should pay the doctor for this not insignificant administrative work.
Claims Hound then sent an email to the treating oncologist requesting that they provide a letter of motivation for the tests DIRECTLY to Discovery so that they do not run afoul of the POPIA legislation.
The specialist oncologist was very helpful and sent a letter of motivation to Discovery.
Unbelievably, they advised that they had reviewed the letter of motivation, provided by THEIR DSP, and found it to be INCOMPLETE. The motivation did not sufficiently outline the clinical indication, presenting symptoms, or rationale linking the tests to the diagnosis and treatment!
This is fascinating considering that Discovery Health (Pty) Ltd views the function of their Medical Advisors as:
“Our Medical Advisors do not provide clinical opinions or guidance on how the member should be treated, as treatment decisions rest entirely with the treating doctor. Their role is to assess applications in accordance with Scheme Rules, plan benefits, clinical entry criteria, and PMB regulations.”
Incidentally, we do not know who these “Medical Advisors” are, what their qualifications are or what their opinions are since these are not provided. (are they nurse practitioners or medical specialists)
Discovery then did the most remarkable thing!
They ACTUALLY contacted the treating service providers and concluded that all but R125,28 of the amounts owed to Lancet was payable.
Claims Hound contacted Lancet and they agreed to write off the outstanding balance.
Claims Hound asked that Discovery Health Medical Scheme reviews the process followed by their administrator, Discovery Health (Pty) Ltd, from an ETHICAL, member perspective.
We do not believe that the INDEPENDENT medical scheme, Discovery Health, reviewed anything!
Instead, their Administrator, Discovery Health (Pty) Ltd, advised that they were satisfied with their conduct and the processes followed. Nothing better than investing your own conduct and concluding you did well.
Perhaps most telling is their view regarding the need to engage with their OWN DSPs.
“There is no requirement for Discovery to proactively engage network providers beyond the approval communication issued at the time of oncology registration. This communication clearly outlines the approved treatment, PMB cover, and the process to follow where additional tests or services outside the basket of care are clinically required.
Where this process is not followed, claims are submitted without prior review and are processed accordingly. This necessitates a retrospective review once additional information is provided.”
The response is however not surprising since this is the same Discovery Health (Pty) Ltd that ATTEMPTED to recover the costs of a pharmacy processing error, MADE BY THEM, from the members of the INDEPENDENT Discovery Health Medical Scheme in 2025.
Similarly, the INDEPENDENT Discovery Health Medical Scheme did not prevent them from doing so at the time.
What prevented them was a major public outcry and legal pressure.
Perhaps the legal pressure should have come from Discovery Health Medical Scheme prior to their Administrator sending nasty letters to the scheme’s members?
In this case, these extra-ordinary theatrics that Discovery performed to make it difficult for their member to claim his PMB benefits, is truly remarkable. (Perhaps this is an isolated case?)
Surely the cost of this theatre production far exceeded the costs of doing the ETHICAL thing and contacting your OWN DSPs in the first instance? (Discovery ended up contacting the DSPs in any event.)
We encourage members to NOT simply pay their outstanding Pathology bills but to challenge their medical schemes for non-payment, especially in the case of PMBs.
Have you had a similar experience? Or even worse, did your medical scheme use your Medical Savings Account (MSA) funds to pay for your PMBs.
Please Comment on, SHARE and LIKE our post and FOLLOW the Claims Hound page.
For assistance, contact Claims Hound via:
Facebook Messenger or by e-mail to [email protected]